Laboratory techniques

Applied Food Diagnostics announces the first reporter-labeled Total QC diagnostic line for food pathogens

Retrieved on: 
Tuesday, July 20, 2021
Natural sciences, Branches of biology, Biology, Laboratory techniques, Molecular biology, Polymerase chain reaction, Real-time polymerase chain reaction, Biotechnology, Green fluorescent protein, Fluorescent protein

BLOOMSBURG, Pa., July 20, 2021 /PRNewswire/ -- Applied Food Diagnostics, Inc. , The World's Most Innovative Microbiology Lab Solutions Company, is pleased to announce a new qPCR diagnostic product line.

Key Points: 
  • BLOOMSBURG, Pa., July 20, 2021 /PRNewswire/ -- Applied Food Diagnostics, Inc. , The World's Most Innovative Microbiology Lab Solutions Company, is pleased to announce a new qPCR diagnostic product line.
  • AFD's breakthrough Total QC-qPCR line of test kits simultaneously detects the target food pathogens along with the reporter-labeled quality control strain, such as Green Fluorescent Protein.
  • Many food pathogen laboratories currently use Green Fluorescent Protein (GFP) tagged positive quality control strains.
  • Applied Food Diagnostics, Inc. (AFD) develops and manufactures sampling and testing products specifically for the food centric sectors.

American Pacific Mining Recaps 2019 and 2020 Drill Results from the Madison Copper Gold Project

Retrieved on: 
Tuesday, July 20, 2021
Physical sciences, Chemistry, Natural sciences, Analytical chemistry, Laboratory equipment, Emission spectroscopy, Gold, Laboratory techniques, Metallurgical assay, Inductively coupled plasma mass spectrometry, Inductively coupled plasma atomic emission spectroscopy, Atomic emission spectroscopy

Drill core samples were analyzed for 48 elements by four-acid digestion of a 0.25-gram sample followed by an ICP-MS (inductively coupled plasma mass spectroscopy) finish.

Key Points: 
  • Drill core samples were analyzed for 48 elements by four-acid digestion of a 0.25-gram sample followed by an ICP-MS (inductively coupled plasma mass spectroscopy) finish.
  • Gold (Au) was also analyzed by fire assay of a 30-gram sample followed by an ICP-AES (inductively coupled plasma atomic emission spectroscopy) finish.
  • About American Pacific Mining Corp.
    American Pacific Mining Corp. is a precious metals explorer focused on opportunities in the Western United States.
  • Also in the American Pacific's asset portfolio are the Gooseberry Gold-Silver project and the Tuscarora Gold project: two high-grade, precious metals projects located in key mining districts of Nevada, USA.

Global EGFR Tests (In Vitro Diagnostics) Market Analysis and Forecast Model 2021 with COVID-19 Market Impact - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 20, 2021
Health, General Health, Branches of biology, Laboratory techniques, Biology, Epidermal growth factor receptor, Oncogenes, Immunohistochemistry, EGFR, In vitro

The "EGFR Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "EGFR Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" report has been added to ResearchAndMarkets.com's offering.
  • EGFR Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.
  • The model discusses in detail the impact of COVID-19 on EGFR Tests market for the year 2020 and beyond.
  • The model includes EGFR Immunohistochemistry Tests, EGFR Sanger Sequencing Tests, EGFR Nucleic Acid Amplification Tests (NAATs), and EGFR Other Tests (EGFR ISH and Mass Array tests).

Mirimus, Inc. Announces Publication of Research in The Lancet-Affiliated Journal EClinicalMedicine Discussing Pooled, Saliva-Based COVID-19 Testing as Efficient, Affordable Surveillance Approach for K-12 Schools

Retrieved on: 
Monday, July 19, 2021
Natural sciences, Molecular biology, Branches of biology, Biology, Laboratory techniques, Biotechnology, Amplifiers, Hoffmann-La Roche, Polymerase chain reaction

The SalivaClear platform provides an efficient and affordable alternative to individual PCR testing.

Key Points: 
  • The SalivaClear platform provides an efficient and affordable alternative to individual PCR testing.
  • As a result, all schools utilizing the SalivaClear testing platform in this study, remained open to in-person learning.
  • The data also demonstrated that pooling saliva samples substantially reduced the cost associated with PCR testing.
  • The research also evaluated the cost of the initial pooled testing, which averaged $10 (range: $8-$12) per individual for all participating schools.

Bionano’s Optical Genome Mapping for Acute Lymphoblastic Leukemia Subjects at the University Hospitals Leuven, Belgium, Has Faster Turnaround Time, Higher Success Rates and Lower Cost per Sample Compared to Traditional Methods

Retrieved on: 
Monday, July 19, 2021
Laboratory techniques, Pediatric cancers, Leukemia, Ogm, Acute lymphoblastic leukemia, Assay, Branches of biology, Medical specialties, Academic disciplines

An assay was developed for whole genome analysis of acute lymphoblastic leukemia (ALL) subjects which, relative to traditional methods, resulted in a workflow with significantly faster turnaround time, higher success rates, and lower cost per sample.

Key Points: 
  • An assay was developed for whole genome analysis of acute lymphoblastic leukemia (ALL) subjects which, relative to traditional methods, resulted in a workflow with significantly faster turnaround time, higher success rates, and lower cost per sample.
  • OGM showed 100% concordance with the traditional methods with no false positives.
  • Dr. Dewaele summarized that their hospital plans to develop more OGM-based assays for other types of leukemias.
  • This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

TellBio’s Scientific Founders Publish Very High Concordance between CTCs and ctDNA from Liquid Biopsies in Patients with Breast Cancer

Retrieved on: 
Thursday, July 15, 2021
Clinical medicine, Medicine, Branches of biology, Laboratory techniques, Molecular biology, DNA, Oncology, Anatomical pathology, Liquid biopsy, Circulating tumor DNA, Biopsy, Digital polymerase chain reaction

The results are published in the July 2021 issue of Breast Cancer Research and Treatment (DOI: 10.1007/s10549-021-06270-z ).

Key Points: 
  • The results are published in the July 2021 issue of Breast Cancer Research and Treatment (DOI: 10.1007/s10549-021-06270-z ).
  • Detection and monitoring of cancer progression is traditionally accomplished via invasive and time-consuming methods including tissue biopsies and/or radiographic scans.
  • CTC detection and analysis is a cutting-edge, next generation approach to liquid biopsies, offering significant advantages to ctDNA-based technologies.
  • Using standard multiplex droplet digital PCR assays, the investigators showed very high concordance (95%) in detecting ESR1 mutations between CTCs and ctDNA.

Curebase, InBios Announce Results of Virtual Clinical Trial of InBios COVID-19 Rapid Detection Test Using Curebase Platform

Retrieved on: 
Wednesday, July 14, 2021
Medicine, Natural sciences, Branches of biology, Immunologic tests, Medical tests, Medical terminology, Biochemistry methods, COVID-19 testing, Laboratory techniques, Immunoassay, COVID-19, Swab

For this study, Curebase converted drive-through COVID-19 testing centers in southern California into clinical research sites with its unique decentralized clinical trial software platform and virtual site support model.

Key Points: 
  • For this study, Curebase converted drive-through COVID-19 testing centers in southern California into clinical research sites with its unique decentralized clinical trial software platform and virtual site support model.
  • This process required no physical interaction with patients and enabled hundreds of people to be screened in a few weeks.
  • The SCoV-2 Ag Detect Rapid Test is a patent-pending lateral flow immunoassay intended for the qualitative detection of SARS-CoV-2 nucleoprotein antigen in direct nasal swab specimens.
  • The point-of-care test r equires no instrumentation or transport media step and can be performed on-site with results delivered in about 20 minutes.

Bionano’s Optical Genome Mapping Reveals New Insights and Prognostic Capabilities Compared to Traditional Cytogenetics Techniques in Several Leukemia Clinical Research Studies Presented at the ECA

Retrieved on: 
Wednesday, July 14, 2021
Branches of biology, Biology, Cytogenetics, Molecular biology, Laboratory techniques, Anatomical pathology, Fluorescence in situ hybridization, Pathology, Karyotype, Ogm, Polymerase chain reaction, Genome

SAN DIEGO, July 14, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced optical genome mapping (OGM) reveals new insights and prognostic capabilities compared to traditional cytogenetics techniques in several leukemia clinical research studies presented at the 2021 European Cytogenomics Conference (ECA).

Key Points: 
  • SAN DIEGO, July 14, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced optical genome mapping (OGM) reveals new insights and prognostic capabilities compared to traditional cytogenetics techniques in several leukemia clinical research studies presented at the 2021 European Cytogenomics Conference (ECA).
  • In this study, 34 pediatric leukemias (26 ALL and 8 AML) were analyzed by OGM relative to traditional cytogenetics techniques (karyotyping, FISH, and PCR).
  • This study is the basis of validation and accreditation of an assay to be used onsite in their lab.
  • In 45% of cases, OGM provided additional information, orthogonally confirmed, demonstrating an improvement in diagnostic potential relative to traditional cytogenetics techniques.

10x Genomics Introduces New Chromium X Series for Single Cell Analysis

Retrieved on: 
Wednesday, July 14, 2021
Natural sciences, Chemistry, Physical sciences, Biochemistry, Laboratory techniques, Genomics, 10x Genomics, 10x, Chromium, Assay, Single-cell analysis, Omics

PLEASANTON, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Building on its industry leading position in single cell analysis, 10x Genomics (NASDAQ: TXG) today announced commercial availability of its new Chromium X Series, a next-generation platform for single cell analysis.

Key Points: 
  • PLEASANTON, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Building on its industry leading position in single cell analysis, 10x Genomics (NASDAQ: TXG) today announced commercial availability of its new Chromium X Series, a next-generation platform for single cell analysis.
  • The Chromium X, which has been in development for more than two years, delivers extensive scale and operational simplicity for single cell analysis.
  • The new Chromium X Series is a milestone for us and our most ambitious project to date, saidBen Hindson, Co-Founder and Chief Scientific Officer of 10x Genomics.
  • The Chromium X Series is compatible with all of the companys existing low throughput and standard single cell assays and is supported by the 10x Genomics Cloud Analysis offering for data management, analysis and collaboration.

Pandemic Response Lab and Brio Announce Partnership to Provide Innovative Molecular Diagnostics Testing Solutions for the Entertainment Industry

Retrieved on: 
Tuesday, July 13, 2021
Research, Infectious diseases, Entertainment, Other Health, TV and Radio, Film & Motion Pictures, Theatre, General Health, Health, Science, Branches of biology, Biology, Life sciences, Molecular biology, Biotechnology, Laboratory techniques, DNA, COVID-19 testing, Whole genome sequencing, Polymerase chain reaction

The Pandemic Response Lab (PRL) and Brio today announced they are partnering to provide COVID-19 testing and variant zone surveillance tracking to mitigate the risk of new and emerging variants for the entertainment industry.

Key Points: 
  • The Pandemic Response Lab (PRL) and Brio today announced they are partnering to provide COVID-19 testing and variant zone surveillance tracking to mitigate the risk of new and emerging variants for the entertainment industry.
  • The partnership will deliver fast, low-cost, end-to-end testing solutions to help ensure the safety of cast and crew members while reducing costs and production downtime.
  • PRL, operated by Opentrons Labworks, Inc. , will conduct the back-end lab work (laboratory diagnostics), including gold-standard PCR testing and genome sequencing of all positive results to track variants.
  • "PRL NYC's vertically integrated approach to lab testing is akin to what has made SpaceX so disruptive to the aerospace industry that makes this already productive partnership even more exciting for us."